TLDR:
2Flo Ventures has announced the addition of renowned life sciences executive Dr. Charlotte Jones-Burton as a partner. Dr. Jones-Burton brings nearly two decades of experience in the biopharmaceutical industry and will lead life science product development and strategy at 2Flo Ventures. Her expertise will enhance the firm’s robust pipeline, which includes companies such as Cancer IQ, Temprian Therapeutics, and Vivacelle Bio. Dr. Jones-Burton’s commitment to advancing health equity aligns with 2Flo’s mission of investing in breakthrough innovations for a healthier future for all.
Article Summary:
2Flo Ventures, a venture capital firm and startup studio focused on healthcare solutions, has welcomed Dr. Charlotte Jones-Burton as a Partner and Head of Life Science Product Development and Strategy. Dr. Jones-Burton has extensive experience in the biopharmaceutical industry and has led clinical development of medicines across various therapeutic areas. She has received multiple awards and serves on the boards of bluebird bio and the American Kidney Fund. Dr. Jones-Burton’s addition to 2Flo Ventures will enhance the firm’s portfolio companies and support the development of innovative therapies. Her commitment to health equity aligns with 2Flo’s mission, and she looks forward to contributing to the firm’s goal of accelerating equitable innovation in healthcare through sound investments and guidance.
